Ovarian Cancer Therapy
New ovarian cancer therapy research has been reported by scientists at Oita University
Published in OBGYN and Reproduction Week, February 19th, 2007
New investigation results, "Apicidin, a novel histone deacetylase inhibitor, has profound anti-growth activity in human endometrial and ovarian cancer cells," are detailed in a study published in International Journal of Molecular Medicine. "Histone deacetylase inhibitors (HDACIs) can inhibit proliferation, induce cell cycle arrest and stimulate apoptosis of cancer cells. Our purpose was to investigate the antiproliferative effects of a novel HDACI, apicidin, on the Ishikawa endometrial cancer cell line, the SK-OV-3 ovarian cancer cell line and normal human endometrial epithelial cells," investigators in Oita, Japan report.
"Endometrial and ovarian cancer cells were...
Want to see the full article?
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of OBGYN and Reproduction Week
More Articles from OBGYN and Reproduction Week
- Breast Cancer
Recent findings from INSERM highlight research in breast cancer - Breast Cancer Prognosis
Recent studies from University of Missouri add new data to breast cancer prognosis - Breast Cancer Therapy
Research on breast cancer therapy detailed by scientists at Baylor College of Medicine - Breast Cancer Therapy
Researchers at Weston Park Hospital publish new data on breast cancer therapy - Breast Cancer Therapy
Researchers from University of Siena report details of new studies and findings in the area of breast cancer therapy - Chlamydia
Research from University of California, Division of Infectious Diseases provide new insights into chlamydia - More from this issue of OBGYN and Reproduction Week
NewsRx is Social
Follow us on your favorite social network by clicking on a button below:
Top Medical Newsletters
Awards
Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005
Facts & Stats
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.
- Google 2010 PageRank: #2 Among Top Health News and Media Publications
- Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
- Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
- Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry
